Torque takes tu­mor tech out of stealth with $25M back­ing, new CEO

Torque Ther­a­peu­tics and its high-pro­file C-suite is step­ping out of stealth to an­nounce a $25 mil­lion round, bankrolled by biotech start­up crew Flag­ship Pi­o­neer­ing.

Re­porters scooped the news back in Au­gust when Torque filed reg­u­la­to­ry pa­per­work sig­nal­ing fundrais­ing ef­forts. The pa­per­work caught the eye of biotech writ­ers due to the star-stud­ded ex­ec­u­tive staff.

The co-founders in­clude Bart Hen­der­son, the for­mer pres­i­dent of Rhythm Phar­ma­ceu­ti­cals (which just snagged $120 mil­lion by go­ing pub­lic); Ul­rik Nielsen, the founder and for­mer CSO of Mer­ri­mack; and Thomas Lars An­dresen, head of mi­cro- and nan­otech­nol­o­gy at Tech­ni­cal Uni­ver­si­ty of Den­mark.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER